Phynova team unveils the OTC product at the GREAT Festival of Creativity.
L-R Zhong Zhong, CEO Phynova (Beijing); Hongwen Yu, Executive VP Phynova (UK) ; Dominic Jeremy, the CEO of UKTI; Robert Miller, CEO Phynova (UK)
2nd March, Shanghai, China: Phynova, the innovative life science company based in Oxford, today announces at The GREAT Festival of Creativity in Shanghai, that it has received the first ever market approval for a traditional Chinese medicine (TCM) from the Medicines and Healthcare Products Regulatory Agency (“MHRA”) for its product, Phynova Joint and Muscle Relief Tablets™(www.phynovajointrelief.com).
This approval marks a significant development in MHRA policy, as this is the first time that the EU’s Traditional Herbal Medicinal Product (“THMP”) Directive, which was introduced in April 2004, has been successfully used to register a TCM product within the UK. This proves Phynova’s diligence in bringing efficacious traditional herbal medicines to the UK and Europe.
Chinese medicine is a high growth market, with ever expanding demand amongst European audiences. Phynova Joint and Muscle Relief Tablets™ is manufactured to Western pharmaceutical standards providing consumers peace of mind and offers a natural alternative treatment to medications such as non-steroidal anti-inflammatory drugs (NSAIDs).
The GREAT Festival of Creativity in Shanghai is a trade mission led by HRH the Duke of Cambridge, sponsored by the British government and is showcasing the best of British innovation. The purpose of this mission is to strengthen bilateral trade links between China and Britain, with a focus on fashion, luxury goods, healthcare, technology and entertainment.
Commenting on receiving MHRA approval, Robert Miller, Chief Executive Officer of Phynova, said: “I am exceedingly proud that Phynova is the first company to successfully bring a traditional Chinese medicine, in a modernised dosage form, through Western regulatory procedures and to receive marketing approval in the UK from the MHRA. This has come from years of working with our Chinese colleagues, and proves that Sino-British collaboration can have major benefits for both parties. The Great Festival of Creativity is a particularly fitting venue for announcing this cross-cultural first in healthcare. Britain can now benefit from having access to high quality, regulated Chinese medicines, and will continue to benefit from the strengthening ties we have with our partners in China as we look to introduce more TCM products into the UK market.”
About Phynova Joint and Muscle Relief Tablets™
A traditional herbal medicinal product used for the relief of backache, minor sports injuries, rheumatic or muscular pains, general aches and pains in the muscles and joints. The OTC is derived from Sigesbeckia which is an annual herb that has been used traditionally in oriental medicine to treat the symptoms of all forms of arthritis and other musculoskeletal pains. Scientific literature reports it has anti-inflammatory, analgesic and anti-oxidant activity.
Visit us at www.phynovajointrelief.com
To read the article in Chinese, please visit the link here.